RCT | Tumor-infiltrating lymphocyte therapy vs. Ipilimumab in advanced melanoma.
8 Dec, 2022 | 12:51h | UTCTumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Patient’s own immune cells effective as living medicine for melanoma – Netherlands Cancer Institute